We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site
Discover the Immunotherapy Funnel & PSI’s Contribution for Accelerating Discovery & Development.
Predict Response: Immunotherapy & Single-Cell Proteomics Evolving Together
In recent years, chemo- and radiotherapies have been supplanted by therapeutics aimed at turning one’s immune system against disease. Cancer immunotherapies, in particular immune checkpoint blockade and combination therapies, have demonstrated remarkable success in treating multiple refractory cancers.
In this E-Book we discuss: